Articles

News, editorials, patient stories, and more.

This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or a qualified healthcare provider before making any health decisions. Full Disclaimer

News

New Oral Pill Shows Promising Results for Lupus in Global Phase 2 Trial

Results from the global WILLOW phase 2 trials show that enpatoran, a first-of-its-kind oral pill targeting the biological triggers of lupus,...

Read More — New Oral Pill Shows Promising Results for Lupus in Global Phase 2 Trial »
Monash University Medicine, Nursing and Health Sciences · May 26, 2026
News

MS Research Roundup: FDA Approves Ocrevus for Children, GLP-1 Drugs Show New Benefits

The May 2026 MS research roundup covers the FDA approval of Ocrevus for pediatric MS, new findings on GLP-1 weight-loss drugs and MS outcome...

Read More — MS Research Roundup: FDA Approves Ocrevus for Children, GLP-1 Drugs Show New Benefits »
Multiple Sclerosis Association of America · May 21, 2026
News

A Lab-Engineered Molecule Named Celiacase Could Change How Celiac Disease Is Managed

Researchers in Barcelona have designed a molecule called celiacase that breaks down the most harmful gluten fragments inside the stomach, be...

Read More — A Lab-Engineered Molecule Named Celiacase Could Change How Celiac Disease Is Managed »
Marina Girbal-González, Arturo Rodríguez-Banqueri, Francisco J. Pérez-Cano, F. Xavier Gomis-Rüth · May 14, 2026
News

New Phase 3 Trial Data Show IVIG Improves Outcomes in Autoimmune Encephalitis

Phase 3 data presented at AAN 2026 show that IVIG significantly improves response rates in autoimmune encephalitis patients who do not respo...

Read More — New Phase 3 Trial Data Show IVIG Improves Outcomes in Autoimmune Encephalitis »
Apr 27, 2026
News

Nearly One in Four Autoimmune Hepatitis Patients Also Has Another Autoimmune Disease, Study Finds

A new study of 371 autoimmune hepatitis patients found nearly 24 percent also had extrahepatic autoimmune diseases, most commonly Sjogren's...

Read More — Nearly One in Four Autoimmune Hepatitis Patients Also Has Another Autoimmune Disease, Study Finds »
Qing-Fang Xiong, Yong-Feng Yang et al. · Apr 21, 2026
Best Supplements for Hashimoto's Thyroiditis: What the Evidence Actually Says Blog

Best Supplements for Hashimoto's Thyroiditis: What the Evidence Actually Says

Managing Hashimoto's thyroiditis often feels like assembling a puzzle with too many pieces. Thyroid medication is typically the foundation o...

Read More — Best Supplements for Hashimoto's Thyroiditis: What the Evidence Actually Says »
AutoimmuneArchive.com Staff · Apr 21, 2026
News

Rezpeg Produces Meaningful Hair Regrowth at One Year in Severe Alopecia Areata, Phase 3 Plans Announced

Extended treatment with Nektar Therapeutics' rezpegaldesleukin produced clinically meaningful hair regrowth in 27% of participants with seve...

Read More — Rezpeg Produces Meaningful Hair Regrowth at One Year in Severe Alopecia Areata, Phase 3 Plans Announced »
Adam Feuerstein · Apr 20, 2026
How to Get the Most Out of a 15-Minute Doctor's Appointment With a Chronic Illness Blog

How to Get the Most Out of a 15-Minute Doctor's Appointment With a Chronic Illness

Fifteen minutes is not a lot of time, especially when you're managing a complex chronic illness with multiple symptoms, multiple medications...

Read More — How to Get the Most Out of a 15-Minute Doctor's Appointment With a Chronic Illness »
AutoimmuneArchive.com Staff · Apr 9, 2026
What Is a Flare, Really? Blog

What Is a Flare, Really?

The word "flare" gets used constantly in autoimmune communities, but it rarely gets a clear definition. If you've been told your disease is...

Read More — What Is a Flare, Really? »
Apr 9, 2026
News

Subcutaneous TEPEZZA Hits the Mark in Phase 3 Trial for Thyroid Eye Disease

Amgen announced that a subcutaneous, on-body injector version of TEPEZZA met its primary and key secondary endpoints in a Phase 3 trial for...

Read More — Subcutaneous TEPEZZA Hits the Mark in Phase 3 Trial for Thyroid Eye Disease »
Amgen Inc. · Apr 6, 2026
Working from Home with Autoimmune Disease: Gear That Helps Me Stay Productive and Comfortable Blog

Working from Home with Autoimmune Disease: Gear That Helps Me Stay Productive and Comfortable

Living with an autoimmune disease often means navigating fatigue, joint pain, brain fog, and other unpredictable symptoms. But that doesn’...

Read More — Working from Home with Autoimmune Disease: Gear That Helps Me Stay Productive and Comfortable »
Mar 31, 2026
News

Phase 3 VALOR Trial Published in NEJM: Brepocitinib Delivers Landmark Results in Dermatomyositis

The Phase 3 VALOR trial, published in the New England Journal of Medicine, found that brepocitinib 30 mg significantly outperformed placebo...

Read More — Phase 3 VALOR Trial Published in NEJM: Brepocitinib Delivers Landmark Results in Dermatomyositis »
Ruth Ann Vleugels, MD, MPH, MBA, et al. · Mar 28, 2026